Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
8/12 | 2,540 USD
-4,87% |
-4,87% |
|
Cabaletta Bio Inc |
9/12 | 2,500 USD
+0,81% |
+0,81% |
|
Calithera Biosciences Inc |
8/12 | 0,000 USD
0,00% |
0,00% |
Cambridge Cognition Holdings plc |
8/12 | 31,500 GBX
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
8/12 | 0,327 USD
+4,47% |
+4,47% |
|
Capricor Therapeutics Inc |
9/12 | 27,380 USD
-4,13% |
-4,13% |
Carbios |
8/12 | 14,700 EUR
-2,91% |
-2,91% |
Cardiol Therapeutics Inc - Class A |
8/12 | 1,390 CAD
-2,80% |
-2,80% |
|
Caredx Inc |
8/12 | 18,900 USD
+2,00% |
+2,00% |
|
Carisma Therapeutics, Inc. |
9/12 | 0,065 USD
+32,65% |
+32,65% |
|
Carmat |
26/09 | 0,099 EUR
0,00% |
0,00% |
|
CASI Pharmaceuticals Inc |
8/12 | 0,930 USD
-3,14% |
-3,14% |
|
Cassava Sciences Inc |
9/12 | 3,240 USD
+1,25% |
+1,25% |
|
Castle Biosciences Inc |
9/12 | 38,250 USD
+0,39% |
+0,39% |
|
Catalyst Pharmaceuticals Inc |
9/12 | 22,550 USD
-2,63% |
-2,63% |
|
Cel-Sci Corp. |
9/12 | 6,660 USD
+6,22% |
+6,22% |
|
Celldex Therapeutics Inc. |
9/12 | 28,090 USD
-5,74% |
-5,74% |
|
Cellectar Biosciences Inc |
9/12 | 3,920 USD
-1,51% |
-1,51% |
|
Cellectis |
8/12 | 4,620 USD
-2,53% |
-2,53% |
|
Cellectis |
9/12 | 4,015 EUR
-1,35% |
-1,35% |
Celyad Oncology |
9/12 | 0,184 EUR
0,00% |
0,00% |
|
Cerus Corp. |
8/12 | 1,870 USD
-9,66% |
-9,66% |
|
Champions Oncology Inc |
8/12 | 6,260 USD
+3,64% |
+3,64% |
|
Charlottes Web Holdings Inc |
8/12 | 0,135 CAD
-3,57% |
-3,57% |
|
Check-Cap Ltd |
8/12 | 1,717 USD
+3,25% |
+3,25% |
|
China Pharma Holdings Inc. |
8/12 | 1,740 USD
+2,35% |
+2,35% |
|
China SXT Pharmaceuticals Inc |
8/12 | 1,380 USD
-2,13% |
-2,13% |
|
Cidara Therapeutics Inc |
9/12 | 220,290 USD
+0,10% |
+0,10% |
|
Cipher Pharmaceuticals Inc |
8/12 | 14,660 CAD
+0,41% |
+0,41% |
|
Citius Pharmaceuticals Inc |
8/12 | 1,120 USD
-5,08% |
-5,08% |
|
Clean Air Metals Inc |
8/12 | 0,060 CAD
-7,69% |
-7,69% |
|
ClearPoint Neuro Inc |
8/12 | 13,690 USD
+1,11% |
+1,11% |
|
Clearside Biomedical Inc |
8/12 | 0,710 USD
-10,13% |
-10,13% |
|
Cns Pharmaceuticals Inc |
8/12 | 7,210 USD
+9,24% |
+9,24% |
|
Co-Diagnostics Inc |
9/12 | 0,363 USD
+4,55% |
+4,55% |
|
Cocrystal Pharma Inc |
8/12 | 1,050 USD
+2,94% |
+2,94% |
|
Cogent Biosciences Inc |
8/12 | 40,300 USD
+3,95% |
+3,95% |
|
Coherus Biosciences Inc |
9/12 | 1,290 USD
+0,78% |
+0,78% |
|
Collegium Pharmaceutical Inc |
8/12 | 47,910 USD
0,00% |
0,00% |
|
CollPlant Biotechnologies Ltd |
8/12 | 2,040 USD
+1,49% |
+1,49% |
Coloplast |
8/12 | 75,440 EUR
-2,86% |
-2,86% |
|
Compass Pathways Plc |
9/12 | 6,360 USD
+0,95% |
+0,95% |
|
Compass Therapeutics Inc |
8/12 | 5,360 USD
-3,07% |
-3,07% |
|
Compugen Ltd. |
9/12 | 1,650 USD
+6,45% |
+6,45% |
|
Conmed Corp. |
8/12 | 40,570 USD
+1,25% |
+1,25% |
|
Convatec Group |
8/12 | 226,400 GBX
-1,22% |
-1,22% |
|
Cooper Companies, Inc. |
8/12 | 78,035 USD
-4,13% |
-4,13% |
|
Corbus Pharmaceuticals Holdings Inc |
8/12 | 10,370 USD
+1,27% |
+1,27% |
|
Corcept Therapeutics Inc |
8/12 | 82,980 USD
-3,63% |
-3,63% |
|
CorMedix Inc |
8/12 | 11,260 USD
+6,63% |
+6,63% |
|
Corvus Pharmaceuticals Inc |
9/12 | 8,670 USD
+1,29% |
+1,29% |
|
Covalon Technologies Ltd. |
8/12 | 1,950 CAD
+1,56% |
+1,56% |
|
Creo Medical Group Plc |
8/12 | 10,400 GBX
+0,24% |
+0,24% |
|
Crescita Therapeutics Inc |
8/12 | 0,450 CAD
0,00% |
0,00% |
|
Crinetics Pharmaceuticals Inc |
9/12 | 47,900 USD
+1,05% |
+1,05% |
|
CRISPR Therapeutics AG |
9/12 | 57,040 USD
-0,56% |
-0,56% |
|
Cronos Group Inc |
9/12 | 2,690 USD
+8,91% |
+8,91% |
|
Crossject |
9/12 | 2,150 EUR
-1,83% |
-1,83% |
|
Cryo-Cell International, Inc. |
8/12 | 4,054 USD
+1,60% |
+1,60% |
|
Cue Biopharma Inc |
8/12 | 0,528 USD
-3,74% |
-3,74% |
|
Cumberland Pharmaceuticals Inc. |
8/12 | 2,170 USD
-9,21% |
-9,21% |
|
CureVac N.V. |
9/12 | 5,120 USD
-1,73% |
-1,73% |
|
Curis Inc |
9/12 | 1,330 USD
-1,48% |
-1,48% |
|
Currenc Group Inc. |
8/12 | 2,330 USD
+3,56% |
+3,56% |
|
Cyanotech Corp. |
8/12 | 0,550 USD
+17,02% |
+17,02% |
|
Cyclerion Therapeutics Inc |
8/12 | 1,690 USD
+0,60% |
+0,60% |
|
Cytokinetics Inc |
9/12 | 61,600 USD
-3,95% |
-3,95% |
|
CytomX Therapeutics Inc |
8/12 | 3,870 USD
-2,03% |
-2,03% |
|
Cytosorbents Corp |
8/12 | 0,724 USD
-0,89% |
-0,89% |